Avacta Group plc Stock
€0.51
Your prediction
Pros and Cons of Avacta Group plc in the next few years
Pros
Cons
Performance of Avacta Group plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Avacta Group plc | 1.000% | - | - | - | - | - | - |
| NetScientific plc | 0.770% | 1.550% | -10.884% | -19.632% | 7.377% | 8.264% | -31.053% |
| Aortech International plc | 7.500% | -2.273% | 31.298% | -81.857% | -11.340% | -94.691% | -89.835% |
| Scientific Digital Imaging plc | -2.420% | -2.419% | -14.184% | -68.490% | -39.500% | -70.050% | - |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Analyzing the financials of a company such as Avacta from the healthcare equipment and supplies industry can be quite intriguing, especially given this sector's potential for innovation and growth amidst skyrocketing healthcare demand. At first glance, Avacta's financial health presents a mixed picture that warrants a thorough investigation to discern its potential and pitfalls.
The initial overview of Avacta's financials suggests a company that is still in its investment and growth phase. With a market capitalization of approximately $433.95 million, which is moderate within the industry, the company's size is neither at the large-cap end of the market nor at the micro-cap, riskier end. The absence of EBITDA profitability, negative earnings per share (EPS), and a revenue stream of $16.03 million TTM (trailing twelve months) paint a picture of a company possibly in its early stages or going through intensive R&D phases that are characteristic of the healthcare equipment & supplies domain.
*Pros: *